 |
|
Faster, more accurate tuberculosis test developed
October 12, 2006Test takes an average of seven days to complete
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Imperial College London, Universidad Peruana Cayetano Heredia, in Lima, Peru, and other institutions have developed a simple and rapid new tuberculosis (TB) test. The test, called microscopic-observation drug-susceptibility or MODS, is more sensitive, faster and cheaper to perform than current culture-based tests. The study is published in the October 12, 2006, issue of the New England Journal of Medicine.
"In the fight to stop the spread of TB, new diagnostic tools are urgently needed to detect TB and multidrug-resistant TB. MODS is just such a tool. It will change the practice of TB testing in developing countries," said Robert H. Gilman, MD, senior author of the study and a professor in the Bloomberg School of Public Health's Department of International Health.
From April 2003 to July 2004, the study authors collected 3,760 sputum-saliva mixed with respiratory discharge-in order to complete sensitivity and susceptibility studies of the MODS test. All samples were decontaminated and then used for parallel MODS testing, as well as for two current gold standard TB tests- the Lowenstein-Jensen culture and automated mycobacterial culture (using the MBBacT system). In order to test the samples using MODS, the researchers observed the cultures under an inverted light microscope for 40 days. The sensitivity of detecting TB was 97.8 percent for MODS culture, 89 percent for automated mycobacterial culture and 84 percent for Lowenstein-Jensen culture, when compared to each other. The median time for detection of TB was 7 days for MODS culture, 13 days for automated mycobacterial culture and 26 days for Lowenstein-Jensen culture.
The researchers also introduced isoniazid, rifampin, ethambutol and streptomycin-TB antibiotics-to the cultures in order to detect drug-resistant TB. Compared to standard culture reference methods, drug-resistant susceptibility agreement for MODS was 100 percent for rifampin, 97 percent for isoniazid, 99 percent for rifampin and isoniazid (combined for multi-drug resistance), 95 percent for ethambutol and 92 percent for streptomycin. MODS results were available, on average, in seven days, making them clinically relevant. Standard antimicrobial tests can take up to several months.
The MODS test relies on three principles: (1) Mycobacterium tuberculosis grows faster in liquid medium than in solid medium; (2) TB grows in characteristic tangles or coils and these characteristic cord formations can be seen microscopically in liquid medium; and (3) the ability to incorporate drugs permits rapid and direct drug-susceptibility testing at the same time as the detection of bacterial growth.
Over 5,000 people die of TB every day worldwide and the poor are disproportionately affected, explained David A.J. Moore, MD, lead author of the study and senior lecturer in infectious diseases and tropical medicine at Imperial College London. \\\
Johns Hopkins University Bloomberg School of Public Health
From April 2003 to July 2004, the study authors collected 3,760 sputum-saliva mixed with respiratory discharge-in order to complete sensitivity and susceptibility studies of the MODS test. All samples were decontaminated and then used for parallel MODS testing, as well as for two current gold standard TB tests- the Lowenstein-Jensen culture and automated mycobacterial culture (using the MBBacT system). In order to test the samples using MODS, the researchers observed the cultures under an inverted light microscope for 40 days. The sensitivity of detecting TB was 97.8 percent for MODS culture, 89 percent for automated mycobacterial culture and 84 percent for Lowenstein-Jensen culture, when compared to each other. The median time for detection of TB was 7 days for MODS culture, 13 days for automated mycobacterial culture and 26 days for Lowenstein-Jensen culture.
The researchers also introduced isoniazid, rifampin, ethambutol and streptomycin-TB antibiotics-to the cultures in order to detect drug-resistant TB. Compared to standard culture reference methods, drug-resistant susceptibility agreement for MODS was 100 percent for rifampin, 97 percent for isoniazid, 99 percent for rifampin and isoniazid (combined for multi-drug resistance), 95 percent for ethambutol and 92 percent for streptomycin. MODS results were available, on average, in seven days, making them clinically relevant. Standard antimicrobial tests can take up to several months.
The MODS test relies on three principles: (1) Mycobacterium tuberculosis grows faster in liquid medium than in solid medium; (2) TB grows in characteristic tangles or coils and these characteristic cord formations can be seen microscopically in liquid medium; and (3) the ability to incorporate drugs permits rapid and direct drug-susceptibility testing at the same time as the detection of bacterial growth.
Over 5,000 people die of TB every day worldwide and the poor are disproportionately affected, explained David A.J. Moore, MD, lead author of the study and senior lecturer in infectious diseases and tropical medicine at Imperial College London. \\\
Johns Hopkins University Bloomberg School of Public Health
Tuberculosis Current Events and Tuberculosis News RSSDisease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
New way to make malaria medicine also first step in finding new antibiotics
University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.
How to differentiate abdominal tuberculosis from lymphomas?
The incidence of tuberculosis is increasing. Lymphadenopathy is the most common manifestation of abdominal tuberculosis and may, in up to 55% of cases without other evidence of abdominal involvement, be easily confused with lymphomas involving abdominal lymph nodes.
New insights could lead to a better pneumococcal vaccine
Discovery of a new, previously unknown mechanism of immunity suggests that there may be a better way to protect vulnerable children and adults against Streptococcus pneumoniae (pneumococcal) infection, say researchers at Children's Hospital Boston and Harvard School of Public Health (HSPH).
Tuberculosis drug shows promise against latent bacteria
A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease.
Novel tuberculosis vaccine in Germany in clinical phase
For the first time in more than 80 years a promising live vaccine against tuberculosis has passed into the clinical phase in Germany: Since Monday of this week the new vaccine, which goes by the designation "VPM1002", has begun safety testing on volunteers in a Phase I clinical trial in Neuss, Germany.
New method to overcome multiple drug resistant diseases developed by Stanford researchers
Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them.
India continues to progress in AIDS vaccine development efforts
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated.
Extensively drug-resistant tuberculosis found in California
In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online.
Comprehensive treatment of extensively drug-resistant TB works, study finds
The death sentence that too often accompanies a diagnosis of extensively drug-resistant tuberculosis (XDR-TB) can be commuted if an individualized outpatient therapy program is followed - even in countries with limited resources and a heavy burden of TB.
More Tuberculosis Current Events and Tuberculosis News Articles
 | The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease by CHARLOTTE ROBERTS, JANE BUIKSTRA Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders.... |
 | Tuberculosis and the Politics of Exclusion: A History of Public Health and Migration to Los Angeles (Critical Issues in Health and Medicine) by Emily K. Abel Though notorious for its polluted air today, the city of Los Angeles once touted itself as a health resort. After the arrival of the transcontinental railroad in 1876, publicists launched a campaign to portray the city as the promised land, circulating countless stories of miraculous cures for the sick and debilitated. As more and more migrants poured in, however, a gap emerged between... |
 | The White Plague: Tuberculosis, Man, and Society by Rene J. Dubos |
 | Living in the Shadow of Death: Tuberculosis and the Social Experience of Illness in American History by Sheila M. Rothman Tuberculosis -- once the cause of as many as one in five deaths in the U.S. -- crossed all boundaries of class and gender, but the methods of treatment for men and women differed radically. While men were encouraged to go out to sea or to the open country, women were expected to stay at home, surrounded by family, to anticipate a lingering death. Several women, however, chose rather to head for... |
 | Captain of Death: The Story of Tuberculosis by Thomas M. Daniel The dramatic story of tuberculosis is told here in a straightforward and accessible style. It presents the stories of persons connected with the disease, either as victims, or as those who made contributions to our knowledge of it; in addition to these personal accounts, the book unfolds the history and explains the pathogenesis of TB. The re-emergence of tuberculosis as a major American public... |
 | Consumed in the City: Observing Tuberculosis at Century's End by Paul Joseph Draus As a public health field worker assigned to control tuberculosis in New York and Chicago in the 1990s, Paul Draus encountered the horrible effects of tuberculosis resurgence in urban areas, and the intersections of disease, blight, and poverty. Consumed in the City grows out of his experiences and offers a persuasive case for thinking about—and treating—tuberculosis as an inseparable... |
 | Tuberculosis Pearls by Neil W. Schluger, Timothy J., M.D. Harkin New York University, New York City. Handbook of 75 clinical case presentations in tuberculosis, with diagnosis, one-page discussion, and pearls. For residents and medical students. Halftone illustrations. DNLM: Tuberculosis, Pulmonary - diagnosis - case... |
 | The Making of a Social Disease: Tuberculosis in Nineteenth-Century France by David S. Barnes In this first English-language study of popular and scientific responses to tuberculosis in nineteenth-century France, David Barnes provides a much-needed historical perspective on a disease that is making an alarming comeback in the United States and Europe. Barnes argues that French perceptions of the disease--ranging from the early romantic image of a consumptive woman to the later view of a... |
 | Clinical Tuberculosis (A Hodder Arnold Publication) by Peter D Davies, Peeter Barnes, Stephen B Gordon Clinical Tuberculosis remains an indispensable resource for respiratory physicians, infectious disease specialists, public health workers and other individuals involved in the management and control of tuberculosis worldwide. This established reference is a comprehensive accoutn of tuberculosis, providing up-to-date and authoritative information on all aspects of the disease. It gives practical... |
 | Contagion and Confinement: Controlling Tuberculosis along the Skid Road by Barron H. Lerner Most historians of tuberculosis have focused on the sanatorium era of the early twentieth century, losing interest in the disease with the discovery of curative antibiotics in the 1940s. In Contagion and Confinement, Barron H. Lerner offers the first in-depth look at the history of tuberculosis control in the antibiotic era, providing a vital account of this neglected chapter in the history of... |
| © 2008 BrightSurf.com |